关注
Lisette de Pillis
Lisette de Pillis
在 hmc.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Linear algebra with applications
SJ Leon, L De Pillis, LG De Pillis
Pearson Prentice Hall, 2006
18192006
A validated mathematical model of cell-mediated immune response to tumor growth
LG de Pillis, AE Radunskaya, CL Wiseman
Cancer research 65 (17), 7950-7958, 2005
6962005
Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
LG de Pillis, W Gu, AE Radunskaya
Journal of theoretical biology 238 (4), 841-862, 2006
6582006
A mathematical tumor model with immune resistance and drug therapy: an optimal control approach
LG De Pillis, A Radunskaya
Computational and Mathematical Methods in Medicine 3 (2), 79-100, 2001
5102001
The dynamics of an optimally controlled tumor model: A case study
LG De Pillis, A Radunskaya
Mathematical and computer modelling 37 (11), 1221-1244, 2003
4662003
A cellular automata model of tumor–immune system interactions
DG Mallet, LG De Pillis
Journal of theoretical biology 239 (3), 334-350, 2006
3562006
Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls
LG de Pillis, W Gu, KR Fister, TA Head, K Maples, A Murugan, T Neal, ...
Mathematical Biosciences 209 (1), 292-315, 2007
2672007
Mathematical model creation for cancer chemo‐immunotherapy
L de Pillis, KR Fister, W Gu, C Collins, M Daub, D Gross, J Moore, ...
Computational and Mathematical Methods in Medicine 10 (3), 165-184, 2009
1762009
A comparison and catalog of intrinsic tumor growth models
EA Sarapata, LG De Pillis
Bulletin of mathematical biology 76, 2010-2024, 2014
1422014
A mathematical model of immune response to tumor invasion
LG de Pillis, A Radunskaya
Computational fluid and solid mechanics 2003, 1661-1668, 2003
1252003
A model of dendritic cell therapy for melanoma
L DePillis, A Gallegos, A Radunskaya
Frontiers in oncology 3, 56, 2013
982013
Mathematical model of tumor–immune surveillance
KJ Mahasa, R Ouifki, A Eladdadi, L de Pillis
Journal of theoretical biology 404, 312-330, 2016
922016
Optimal control of mixed immunotherapy and chemotherapy of tumors
LG de Pillis, KR Fister, W Gu, T Head, K Maples, T Neal, A Murugan, ...
Journal of Biological systems 16 (01), 51-80, 2008
912008
Modeling cancer-immune responses to therapy
LG DePillis, A Eladdadi, AE Radunskaya
Journal of pharmacokinetics and pharmacodynamics 41, 461-478, 2014
862014
Spatial tumor‐immune modeling
LG de Pillis, DG Mallet, AE Radunskaya
Computational and Mathematical Methods in medicine 7 (2-3), 159-176, 2006
652006
Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach
KJ Mahasa, A Eladdadi, L De Pillis, R Ouifki
Plos one 12 (9), e0184347, 2017
642017
Are engineering schools masculine and authoritarian? The mission statements say yes.
E De Pillis, L de Pillis
Journal of Diversity in Higher Education 1 (1), 33, 2008
642008
Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
KJ Mahasa, L De Pillis, R Ouifki, A Eladdadi, P Maini, AR Yoon, CO Yun
Scientific reports 10 (1), 425, 2020
522020
Mathematical modeling of the regulatory T cell effects on renal cell carcinoma treatment
LG de Pillis
492013
Linear algebra with applications
SJ Leon
Pearson, 2014
452014
系统目前无法执行此操作,请稍后再试。
文章 1–20